Advertisement DelSite initiates licensing program for its biologic raw materials - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

DelSite initiates licensing program for its biologic raw materials

DelSite, a research-based, biopharmaceutical and consumer products company, has announced that in order to protect its proprietary raw material Manapol from cheap, ineffective, foreign raw materials, it has initiated a licensing program for its raw materials including Manapol.

There are currently no agreements that preclude the broad and lawful licensing of these products, the company said.

According to the company, Manapol is a biologic raw material produced as a product by process which ensures quality and consistency. Manapol is used in DelSite’s AloeCeuticals product line. Manapol is also used to fortify various nutraceutical drinks made from fresh aloe gel.